993 resultados para ADAM, TAPI, CDC42


Relevância:

10.00% 10.00%

Publicador:

Resumo:

7

Relevância:

10.00% 10.00%

Publicador:

Resumo:

1 [First Fascicle]

Relevância:

10.00% 10.00%

Publicador:

Resumo:

1 [Second Fascicle]

Relevância:

10.00% 10.00%

Publicador:

Resumo:

9

Relevância:

10.00% 10.00%

Publicador:

Resumo:

5

Relevância:

10.00% 10.00%

Publicador:

Resumo:

4

Relevância:

10.00% 10.00%

Publicador:

Resumo:

2

Relevância:

10.00% 10.00%

Publicador:

Resumo:

3

Relevância:

10.00% 10.00%

Publicador:

Resumo:

pt.11 (1852) [Anoplura, or Parasitic Insects]

Relevância:

10.00% 10.00%

Publicador:

Resumo:

pt.5 (1856) [Lepidoptera]

Relevância:

10.00% 10.00%

Publicador:

Resumo:

A divulgação de possíveis conflitos de interesses (COI) é um recurso utilizado por revistas científicas biomédicas para garantir a credibilidade e transparência do processo científico. No entanto, a divulgação de COI não constitui um foco sistemático ou consistente das revistas científicas. As recentes ações editoriais conjuntas prepararam o terreno para a implementação de veículos uniformes para a divulgação de COI. Este artigo fornece uma perspectiva editorial abrangente de questões clássicas associadas a COI. Discutem-se, ademais, perspectivas sobre as políticas e práticas atuais de COI de revistas científicas de cardiologia nacionais da Sociedade Europeia de Cardiologia, tendo como base uma pesquisa transversal utilizando um questionário padronizado.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Abstract Background: The use of aortic counterpulsation therapy in advanced heart failure is controversial. Objectives: To evaluate the hemodynamic and metabolic effects of intra-aortic balloon pump (IABP) and its impact on 30-day mortality in patients with heart failure. Methods: Historical prospective, unicentric study to evaluate all patients treated with IABP betwen August/2008 and July/2013, included in an institutional registry named TBRIDGE (The Brazilian Registry of Intra-aortic balloon pump in Decompensated heart failure - Global Evaluation). We analyzed changes in oxygen central venous saturation (ScvO2), arterial lactate, and use of vasoactive drugs at 48 hours after IABP insertion. The 30-day mortality was estimated by the Kaplan-Meier method and diferences in subgroups were evaluated by the Log-rank test. Results: A total of 223 patients (mean age 49 ± 14 years) were included. Mean left ventricle ejection fraction was 24 ± 10%, and 30% of patients had Chagas disease. Compared with pre-IABP insertion, we observed an increase in ScvO2 (50.5% vs. 65.5%, p < 0.001) and use of nitroprusside (33.6% vs. 47.5%, p < 0.001), and a decrease in lactate levels (31.4 vs. 16.7 mg/dL, p < 0.001) and use of vasopressors (36.3% vs. 25.6%, p = 0.003) after IABP insertion. Thirty-day survival was 69%, with lower mortality in Chagas disease patients compared without the disease (p = 0.008). Conclusion: After 48 hours of use, IABP promoted changes in the use of vasoactive drugs, improved tissue perfusion. Chagas etiology was associated with lower 30-day mortality. Aortic counterpulsation therapy is an effective method of circulatory support for patients waiting for heart transplantation.